SCHEMBL2965031

SCHEMBL2965031

Brc1ccc2c(c1)CC(c1cccs1)=C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.35
MEN1 O00255 5/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 4/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
PPARG P37231 2/20 0.35
RXFP1 Q9HBX9 2/20 0.35
PRNP P04156 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
ABL1 P00519 1/20 0.34
BCR P11274 1/20 0.34
MAPT P10636 5/20 0.33
RAB9A P51151 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 2/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2973538 0.88 TRPA1 (0.41) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL7172908 0.78 CYP11B2 (0.44) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL2964136 0.73 CYP11B1 (0.42) ALDH1A1TDP1TRPA1SLC6A2HTR2A
SCHEMBL2968956 0.70 LTA4H (0.35) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL2974362 0.70 GRM5 (0.37) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL21291331 0.69 MAPT (0.35) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL2964034 0.69 PIK3R1 (0.42) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL2973732 0.69 ALDH1A1 (0.37) ALDH1A1TRPA1SLC6A2HTR2AHTR2C
SCHEMBL2966220 0.67 CA1 (0.38) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL2972467 0.67 RAPGEF4 (0.34) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 KMT2A 1517/4885MEN1 750/4885KDM4E 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.